In July 2025, Recursion Pharmaceuticals acquired Rallybio’s full stake in their joint venture for developing REV102 and an associated backup molecule for the treatment of hypophosphatasia.

OpenAI said the new Norway-based data center comes as the European Union races to achieve AI sovereignty by investing in data center and compute power.

U.S. Economy Slowed in First Half of 2025 as Tariffs Scrambled Data Gross domestic product rebounded in the spring after contracting at the start of the year, but consumer spending remained weak.